MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Nephros Langfristige Verbindlichkeiten 2011-2026 | NEPH
Langfristige Verbindlichkeiten Jährlich Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.61 M | 1.51 M | 1.11 M | 1.16 M | 1.12 M | 347 K | 7.8 M | - | 707 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.8 M | 347 K | 1.92 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Alcon
ALC
|
6.05 B | $ 75.4 | -0.8 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 11.21 | -1.41 % | $ 27.2 M | USA |
 |
The Cooper Companies
COO
|
1.54 B | $ 63.09 | -1.94 % | $ 12.6 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 121.01 | -1.5 % | $ 2.98 B | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 125.44 | -0.41 % | $ 4.01 B | USA |
 |
Haemonetics Corporation
HAE
|
405 M | $ 59.84 | -1.06 % | $ 3.01 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 6.15 | 1.32 % | $ 52.2 K | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 4.08 | 0.49 % | $ 188 M | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 466.64 | -0.92 % | $ 167 B | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 2.1 | -3.23 % | $ 96.2 M |  Israel |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 119.63 | -2.0 % | $ 5.79 B | USA |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.33 | -4.15 % | $ 27.1 M | USA |
 |
Masimo Corporation
MASI
|
56 M | $ 178.51 | -0.08 % | $ 9.51 B | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 10.18 | -4.5 % | $ 210 M | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 66.74 | -1.02 % | $ 3.95 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 26.49 | -1.05 % | $ 4.45 B | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 21.83 | -3.62 % | $ 1.47 B | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.62 | -2.99 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 51.51 | -0.87 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 112.4 | -1.85 % | $ 2.54 B | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 26.7 | 0.07 % | $ 1.32 B | USA |
 |
STERIS plc
STE
|
1.53 B | $ 219.75 | -1.1 % | $ 21.7 B | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 135.52 | 0.33 % | $ 6.05 B | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 20.9 | -2.38 % | $ 963 M | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 1.86 | -3.63 % | $ 169 M | USA |
 |
Baxter International
BAX
|
7.05 B | $ 17.94 | -2.97 % | $ 9.2 B | USA |
 |
ResMed
RMD
|
1.05 B | $ 217.14 | -2.2 % | $ 31.7 B | USA |
 |
AtriCure
ATRC
|
261 M | $ 28.48 | -1.93 % | $ 1.36 B | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 66.61 | -0.25 % | $ 216 M | USA |
 |
Harvard Bioscience
HBIO
|
58.5 M | $ 6.45 | -5.56 % | $ 286 M | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 292.13 | -3.33 % | $ 21.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 11.78 | -1.51 % | $ 2.35 B | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 10.98 | -0.99 % | $ 449 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25 B | $ 149.52 | -0.47 % | $ 43 B | USA |
 |
OraSure Technologies
OSUR
|
22.5 M | $ 3.01 | - | $ 221 M | USA |
 |
Repligen Corporation
RGEN
|
701 M | $ 117.43 | -0.73 % | $ 6.54 M | USA |